A PHASE 1 TRIAL OF THE ONCOLYTIC VIRUS SVV-001 IN COMBINATION WITH NIVOLUMAB AND IPILIMUMAB IN PATIENTS WITH HIGH GRADE NEUROENDOCRINE NEOPLASMS

Category Primary study
Conference40th Annual Meeting of Society for Immunotherapy of Cancer, SITC 2025
Year 2025
This article has no abstract
Epistemonikos ID: 9428bc2222a172020629f898d3ac179aee093b5c
First added on: Dec 12, 2025